| Original language | English |
|---|---|
| Journal | Movement Disorders |
| Volume | 33 |
| Issue number | 6 |
| Pages (from-to) | 1025-1027 |
| Number of pages | 3 |
| ISSN | 0885-3185 |
| DOIs | |
| Publication status | Published - 01.06.2018 |
Funding
Funding agencies: Deutsche Parkinson Gesellschaft (DPG); EPIPARK: Deutsche Forschungsgemeinschaft (DFG) KA 3179/2-1; DFG FOR2488 (Z2); Depression-PD: University of Rostock, Rostock, Germany; PRIPS-Homburg and PRIPS-Tu€bingen: The PRIPS study was supported by the Michael J. Fox Foundation, the Bosch GmbH, and the Walter AG with help in recruitment and the retention of participants. TREND: the TREND study is being conducted at the University Hospital of Tuebingen and supported by the German Center for Neurodegenerative Diseases and the Hertie Institute for Clinical Brain Research. Additional third-party funding had been granted by the Centre for Integrative Neuroscience, Tu€bingen, Germany. A substudy had been supported by TEVA Pharmaceutical Industries Ltd. Further sponsors of TREND are Union Chimique Belge (UCB) and Janssen Pharmaceuticals Inc, Lundbeck, as well as the International Parkinson Fonds.
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)